NCT04913376View on ClinicalTrials.gov

Hilotherapy-study on Prevention of Oxaliplatin-induced Peripheral Neuropathy

NACompletedINTERVENTIONAL

Enrollment

66

Participants

Timeline

Start Date

May 17, 2021

Primary Completion Date

October 25, 2022

Study Completion Date

October 25, 2022

Conditions

Quality of LifeChemotherapy-induced Peripheral Neuropathy

Interventions

DEVICE

Hilotherapy

Constant cooling device for hands and feet.

Trial Locations (1)

3000

UZ Leuven, Leuven

All Listed Sponsors

lead

Universitaire Ziekenhuizen KU Leuven

OTHER